KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBT Margin (2016 - 2025)

Historic EBT Margin for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 39.04%.

  • Merck's EBT Margin rose 144900.0% to 39.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.96%, marking a year-over-year increase of 122500.0%. This contributed to the annual value of 31.07% for FY2024, which is 279300.0% up from last year.
  • Merck's EBT Margin amounted to 39.04% in Q3 2025, which was up 144900.0% from 31.63% recorded in Q2 2025.
  • Over the past 5 years, Merck's EBT Margin peaked at 40.03% during Q3 2021, and registered a low of 35.48% during Q2 2023.
  • In the last 5 years, Merck's EBT Margin had a median value of 28.91% in 2021 and averaged 24.57%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -662300bps in 2023, then skyrocketed by 727600bps in 2024.
  • Merck's EBT Margin (Quarter) stood at 28.91% in 2021, then decreased by -12bps to 25.4% in 2022, then crashed by -155bps to 13.98% in 2023, then skyrocketed by 291bps to 26.69% in 2024, then surged by 46bps to 39.04% in 2025.
  • Its EBT Margin stands at 39.04% for Q3 2025, versus 31.63% for Q2 2025 and 38.01% for Q1 2025.